Yvette L. Kasamon

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma”.

FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1272

N/A

1.4DataRank · unranked

35 citations

Yvette L. Kasamon, Justin S. Collazo, Ruby Leong, Kun Wang, P Li +8 more

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances

JAMA(2021)10.1001/jama.2021.9941

N/A

0.864DataRank · unranked

317 citations

Peter Gill, Davina Ghersi, Lisa Campbell, Jeremy Sugarman, Richard Emsley +41 more

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Blood(2021)10.1182/blood.2021013443

N/A

0DataRank · unranked

119 citations

Shannon R. McCurdy, Scott R. Solomon, Tao Wang, Megan M. Herr, Dipenkumar Modi +18 more

FDA Approval Summary: Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0568

N/A

0DataRank · unranked

24 citations

Yvette L. Kasamon, Xue Lin, Zhenzhen Xu, Marc R. Theoret, Tejashri Purohit-Sheth +1 more

Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3579

N/A

0DataRank · unranked

11 citations

Maryam Sarraf Yazdy, Yvette L. Kasamon, Rachel Ershler, Emily Y. Jen, Bindu Kanapuru +7 more

FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1729

N/A

0DataRank · unranked

7 citations

Yvette L. Kasamon, Wenjuan Gu, Lisa R. Rodriguez, Susan Jin, Vishal Bhatnagar +5 more